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Abstract
Background: Previous studies of inter-practice variation of the prevalence of hypertension and
diabetes mellitus showed wide variations between practices. However, in these studies inter-
practice variation was calculated without controlling for clustering of patients within practices and
without adjusting for patient and practice characteristics. Therefore, in the present study inter-
practice variation of diagnosed hypertension and diabetes mellitus prevalence rates was calculated
by 1) using a multi-level design and 2) adjusting for patient and practice characteristics.
Methods: Data were used from the Netherlands Information Network of General Practice
(LINH) in 2004. Of all 168.045 registered patients, the presence of hypertension, diabetes mellitus
and all available ICPC coded symptoms and diseases related to hypertension and diabetes, were
determined. Also, the characteristics of practices were used in the analyses. Multilevel logistic
regression analyses were performed.
Results: The 95% prevalence range for the practices for the prevalence of diagnosed hypertension
and diabetes mellitus was 66.3 to 181.7 per 1000 patients and 22.2 to 65.8 per 1000 patients,
respectively, after adjustment for patient and practice characteristics. The presence of
hypertension and diabetes was best predicted by patient characteristics. The most important
predictors of hypertension were obesity (OR = 3.5), presence of a lipid disorder (OR = 3.0), and
diabetes mellitus (OR = 2.6), whereas the presence of diabetes mellitus was particularly predicted
by retinopathy (OR = 8.5), lipid disorders (OR = 2.8) and hypertension (OR = 2.7).
Conclusion: Although not the optimal case-mix could be used in this study, we conclude that even
after adjustment for patient (demographic variables and risk factors for hypertension and diabetes
mellitus) and practice characteristics (practice size and presence of a practice nurse), there is a
wide difference between general practices in the prevalence rates of diagnosed hypertension and
diabetes mellitus.
Background
The prevalence rate of chronic diseases like hypertension
and diabetes mellitus is rapidly increasing, particularly in
industrialized countries [1,2]. Since hypertension and dia-
betes mellitus are major risk factors for the development
of cardiovascular and renal diseases, and could result in
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diseases is warranted. In the Netherlands, most hyperten-
sive and diabetic patients are detected and treated by a
General Practitioner (GP). Dutch GPs have a gatekeeper
role for access to specialized care. All Dutch inhabitants
are listed with a general practice and generally the GP is
the first professional to be consulted for health problems.
According to the guidelines of the Dutch College of Gen-
eral Practitioners, measurement of blood pressure and
blood glucose are recommended in specific patient
groups [5,6]. It could be hypothesized that when all GPs
are following these guidelines, there should be no vari-
ance between general practices, i.e. inter-practice varia-
tion, in the prevalence rates of diagnosed hypertension
and diabetes mellitus after adjustment for patient charac-
teristics in a practice. Demographic characteristics of the
patients in a general practice, like age and gender, can
influence the prevalence rates of diagnosed hypertension
and diabetes mellitus in a practice, but the prevalence
rates can also be affected by an unequal distribution of
risk factors between populations of different practices.
Previous studies of inter-practice variation of the preva-
lence rate of hypertension and diabetes mellitus showed a
wide variation at practice level. However, in these studies
inter-practice variation was calculated without controlling
for clustering of patients within practices and without
adjusting for patient and practice characteristics [7-11].
Multilevel analyses takes the statistical dependency of
patients within practices into account. Furthermore, inter-
practice variance can be adjusted for factors influencing
prevalence rates at the level of patients and practices. Usu-
ally this results in fewer significant findings at the higher
hierarchical level (in this case: practices).
Therefore, the purpose of this study is, first, to assess inter-
practice variation of diagnosed hypertension and diabetes
mellitus prevalence rates using a multi-level design. Sec-
ond, we will study to what extent practice variation can be
explained by specific characteristics of the practices
involved at either the patient level (such as age, gender
and the presence of risk factors), or in terms of practice
characteristics (such as practice type or the level of practice
support personnel).
Methods
Study population
Data were used from the Netherlands Information Net-
work of General Practice (LINH). These data were
retrieved from electronic medical records kept by a repre-
sentative sample of 75 GP practices in 2004. Data include
information on consultations, morbidity, prescriptions
and referrals. Practices as well as patients are representa-
tive for the Dutch population [12,13]. Patients under 25
were excluded, because of their low probability of having
hypertension and/or diabetes mellitus. Practices who
recorded during less than six months in 2004 were
excluded from statistical analyses.
The study was carried out according to Dutch legislation
on privacy. The privacy regulation of the study was
approved by the Dutch Data Protection Authority.
According to Dutch legislation, nor obtaining informed
consent nor approval by a medical ethics committee was
obligatory for observational studies.
Classification of hypertension and diabetes mellitus
Morbidity data were derived from consultation diagnoses
and furthermore from all prescriptions issued by the par-
ticipating practices. Diagnoses were recorded using the
ICPC-1 coding system (International Classification of Pri-
mary Care) [14]. When issuing a prescription, a diagnostic
code was recorded, and the selected drug was automati-
cally linked to the Anatomical Therapeutic Chemical
(ATC) Classification System. [15].
Patients were classified as hypertensive when one of the
following criteria was fulfilled: 1) diagnosed at any con-
sultation as uncomplicated hypertension or as hyperten-
sion with involvement of target organs (ICPC code K86
and K87, respectively) and/or 2) any prescription of one
of the following medicines for hypertension: antihyper-
tensives (ATC code C02), diuretics (ATC code C03), beta-
blockers (ATC code C07), calcium blockers (ATC code
C08) and/or ACE-inhibitors (ATC code C09). Patients
were classified as diabetic when the GP recorded the diag-
nosis diabetes mellitus (ICPC code T90) at any consulta-
tion or prescribed insulin (ATC code A10A) or oral blood
glucose lowering drugs (ATC code A10B). It was not pos-
sible to discriminate between diabetes mellitus type 1 and
type 2, because there are no different ICPC codes for these
types.
The prevalence rates of diagnosed hypertension and dia-
betes mellitus were calculated by counting the number of
patients who fulfilled the above mentioned criteria in
2004 or in any previous year (up to 1997 when LINH
started). The total number of patients registered in the
participating general practices in 2004 was used as the
denominator. The prevalence rates of diagnosed hyper-
tension and diabetes mellitus were calculated for men and
women separately in the following age groups: 25–44
years, 45–64 years, 65–74 years and 75 years and older.
Patient and practice characteristics
Patient and practice characteristics were used to study
which factors could explain the inter-practice variation of
diagnosed hypertension and diabetes mellitus prevalence
rates. The patient characteristics consisted of demographicPage 2 of 6
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patients in a general practice can influence the prevalence
rates of diagnosed hypertension and diabetes mellitus in
a practice, but the prevalence rates can also be affected by
an unequal distribution of risk factors between popula-
tions of different practices. The demographic variables
were age and gender. Furthermore, type of health care
insurance (public or private) was included as an indicator
for socio-economic status, derived from the electronic
medical records (the 60% people with lower incomes in
the Netherlands are publicly insured, the 40% people
with higher incomes are privately insured).
We also included a number of risk factors for hyperten-
sion and diabetes mellitus at patient level. The morbidity
variables were all symptoms and diseases in case of which
the GP should measure blood pressure and/or blood glu-
cose according to the guidelines of the Dutch College of
General Practitioners. According to these guidelines,
blood pressure should be measured in 1) patients with
symptoms related to a cardiovascular disease, 2) patients
with cardiovascular disease, 3) patients with an increased
risk of developing a heart disease and 4) patients who use
a drug with cardiovascular side effects [5]. Blood glucose
should be measured in 1) patients with symptoms related
to diabetes mellitus, 2) diseases caused by diabetes melli-
tus and 3) patients aged 45 years and older with risk fac-
tors for diabetes mellitus [6]. The used ICPC coded
symptoms and diseases are presented in table 1.
Differences in the size and the organization structure of
practices can also influence the prevalence rates of diag-
nosed hypertension and diabetes mellitus in the practices.
Therefore the following practice characteristics were used
in the analyses: type of practice (solo, duo, group or
health centre) and the presence of a practice nurse. It was
not possible to use variables at GP level, since GPs in
group practices and health centers usually do not have
personal patient lists.
Statistical analyses
Multilevel logistic regression analyses with a random
intercept were performed using the second order PQL
method [16]. The aim of our study is the inter-practice
variation, which is estimated by the between practice var-
iation in the multilevel models. This variation is due to
differences in the practice population (for instance differ-
ences in age or gender structure of the practice popula-
tion) and to contextual effects, such as environmental
effects (for instance degree of urbanization or local cul-
ture) or practice effects (for instance attitudes of doctors or
staffing of the practice). For both dependent variables (the
presence of diagnosed hypertension and diabetes melli-
tus), three logistic regression models were calculated: 1) a
null model with only the intercept, 2) model 1 plus
patient characteristics 3) model 2 plus practice character-
istics. For all models the between practice variation and
the intercept of the model were used to estimate the 95%
prevalence range for the practices (intercept plus and
minus 1.96 times the square root of the between practice
variation and transformed back from a logit scale). Cov-
Table 1: ICPC coded symptoms and diseases
Hypertension Diabetes mellitus
Symptoms of cardiovascular disease (K01-K29)1
Ischemic heart disease with angina (K74) Ischemic heart disease with angina (K74)
Heart failure (K77) Heart failure (K77)
Stroke/cerebro-vasculair accident (K90) Stroke/cerebro-vasculair accident (K90)
Atherosclerosis/PVD (K92) Atherosclerosis/PVD (K92)
Hypertension2
Excessive thirst (T01)
Obesity (T82) Obesity (T82)
Overweight (T83) Overweight (T83)
Lipid disorder (T93) Lipid disorder (T93)
Retinopathy (F83)
Renal disease (symptoms or chronic disease)3 Renal disease (symptoms or chronic disease)3
Diabetes mellitus2
1 At least one of the following symptoms: Heart pain (K01), Pressure/Tightness of heart (K02), Cardiovascular pain not otherwise specified (K03), 
Palpitations/awareness of heart (K04), Irregular heartbeat other (K05), Prominent veins (K06), Swollen ankles/oedema (K07), Fear of heart disease 
(K24), Fear of hypertension (K25), Fear of cardiovascular disease other (K27), Limited function/disability (K28), Cardiovascular symptoms/
complaints other (K29).
2 As described in section 'Classification of hypertension and diabetes mellitus'
3 At least one of the following symptoms/diseases: Pyelonephritis/pyelitis (U70), Malignant neoplasm of kidney (U75), Malignant neoplasm of bladder 
(U76), Malignant neoplasm urinary other (U77), Neoplasm urinary tract not otherwise specified (U79), Injury urinary tract (U80), Congenital 
anomaly urinary tract (U85), Glomerulonephritis/nephrosis (U88), Urinary calculus (U90), Abnormal urine test not otherwise specified (U98), 
Urinary disease other (U99)Page 3 of 6
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explain the between practice variation. The range after the
most complex model (model 3), is an indication of the
left over, unexplained, inter-practice variation that could
not be explained by the covariates. Age was added to the
model as a polynomial function, since the association of
age with the dependent variables was non-linear.
Model 3 was also used to determine which patient and
general practice characteristics were the best predictors of
the existence of diagnosed hypertension and diabetes
mellitus in an individual patient by calculating odds
ratio's (ORs). All statistical analyses were performed with
MLwiN, a statistical program for multilevel analyses [17].
Results
Population characteristics
In 2004, data of 58 out of the 75 (77%) participating
LINH practices could be used for statistical analyses,
including 168.045 registered patients. 17 practices had to
be excluded because of (partly) missing data. The charac-
teristics of the studied population were representative for
the Dutch population in terms of gender and age (Statis-
tics Netherlands, http://www.cbs.nl; data not shown).
Prevalence of hypertension and diabetes mellitus
The prevalence rates of diagnosed hypertension and dia-
betes mellitus in 2004, classified by age group and gender,
are shown in table 2. The mean prevalence rate of diag-
nosed hypertension was 142.0 per 1000 persons. In all
age categories, the prevalence rate of diagnosed hyperten-
sion was higher for women compared with men. The
highest prevalence rate of diagnosed hypertension was
found in 75+ aged women (448.6/1000 persons). The
mean prevalence rate of diagnosed diabetes was 60.3 per
1000 persons in 2004. The prevalence rate of diagnosed
diabetes mellitus was higher in women compared to men,
except for the age category 45–64 years. The highest prev-
alence rate was found for 75+ aged women (190.7/1000
persons).
Inter-practice variation of hypertension and diabetes 
mellitus
Multilevel logistic regression models for the prevalence
rates of diagnosed hypertension and diabetes mellitus are
shown in table 3 and 4 (see Additional file 1). The inter-
cept of the model and the variance at practice level were
used to calculate the 95% prevalence range for the prac-
tices in the three models. In model 1 the prevalence rate
of diagnosed hypertension and diabetes mellitus in prac-
tices varied between 77.9 and 238.7 per 1000 patients and
between 30.0 and 109.7 per 1000 patients, respectively.
For hypertension, the variance at practice level dropped
24.1% after adjustment for patient and practice character-
istics, resulting in a range between practices of 66.3 to
181.7 per 1000 patients. The variance at practice level
decreased 32.3% for diabetes mellitus after adding patient
and practice characteristics to the model, resulting in a
inter-practice range of 22.2 to 65.8 per 1000 patients.
The most important predictors of having a diagnosis of
hypertension were the following patient characteristics:
obesity (OR = 3.5), presence of a lipid disorder (OR =
3.0), and the presence of diabetes mellitus (OR = 2.6).
There were no statistically significant associations
between practice characteristics and the presence of hyper-
tension.
Retinopathy (OR = 8.5), lipid disorders (OR = 2.8) and
hypertension (OR = 2.7) were the most important predic-
tors of the presence of diabetes mellitus. Of all practice
characteristics, only practice type was associated with dia-
betes mellitus (OR = 1.3). In a group practice the chance
of having diabetes mellitus was higher compared with
solo practices.
Discussion
The inter-practice variation of the prevalence rates of diag-
nosed hypertension and diabetes mellitus was 66.3 to
181.7 per 1000 patients and 22.2 to 65.8 per 1000
patients, respectively, after adjustment for patient and
practice characteristics. The presence of diagnosed hyper-
tension and diabetes was best predicted by patient charac-
teristics. The most important predictors of hypertension
were the presence of obesity, a lipid disorder and diabetes
mellitus, whereas the presence of diabetes mellitus was
particularly predicted by retinopathy, lipid disorders and
hypertension.
Table 2: The prevalence of hypertension and diabetes mellitus in general practice, classified by age and gender in 2004 (per 1000 
persons).
Total (% CI) 25–44 years 45–64 years 65–74 years 75+ years
M F M F M F M F
Hypertension 142.0 (140.3 – 143.6) 22.8 29.7 152.2 174.1 306.6 376.9 341.4 448.6
Diabetes Mellitus 60.3 (59.2 – 61.5) 12.0 12.2 69.1 57.4 151.6 159.3 165.0 190.7Page 4 of 6
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tension and diabetes mellitus has been studied previ-
ously, but without using multi-level statistical techniques
[7-11]. We expected that the variation between practices
would be lower if the appropriate multilevel techniques
were applied. However, the results of the present study are
fully in line with these previous studies and still show a
wide inter-practice variance of the prevalence of diag-
nosed hypertension and diabetes mellitus, even after cor-
recting for the characteristics of the practice populations.
Ideally, there should be no practice variation in the prev-
alence rates of diagnosed hypertension and diabetes mel-
litus after adjustment for demographic, socio-economic
or case-mix variables. Our results show that we are far
from this ideal situation, since inter-practice variation
could not be explained by the used demographic or case
mix indicators in the present study. In addition, we hardly
found any support for the idea that practice size or the
presence of auxiliary staff in the practice would be an
important factor. These results suggests that much can be
improved in the detection of hypertension and diabetes
mellitus in general practice in the Netherlands. In addi-
tion, it leaves us empty handed with respect to possible
solutions; so far the variation seems to be random.
Of course this study has its limitations. We could not, for
example, include all relevant risk factors for hypertension
and diabetes mellitus. Smoking status, use of alcohol,
body mass index, physical activity and family history of
cardiovascular diseases and diabetes mellitus, are not
recorded by GPs in a systematic way and therefore could
not be used in this study. The same applies to a more
detailed measurement of socio-economic status or depri-
vation and ethnic background. We could only use type of
health care insurance as an indicator for socio-economic
status, since this is the only socioeconomic parameter
which is recorded in the electronic medical records. It is
possible that our results would have been different if these
risk factors were included. Furthermore, most of the
symptoms and diseases used in the statistical models had
a low prevalence, which makes discrimination between
practices more difficult. Also at practice level (or prefera-
bly even a separate GP level), a number of possibly rele-
vant factors could not be included. It would be interesting
to investigate the effect of age, gender and years of experi-
ence of the GP. However, this was not possible since GPs
in group practices and health center usually do not have
personal patient lists. Moreover, it is possible that differ-
ences in the pro-active attitude of GPs in the studied dis-
ease could explain a part of the remaining variance. It
would be interesting to compare our results with identical
analyses of GP data in the UK to establish whether finan-
cial incentives from the Quality and Outcomes Frame-
work (QOF) would reduce the inter-practice variation
[18].
In spite of these limitations, however, we believe the most
important and plausible factors to account for between
practice variation have been included in this study. And
yet a large amount of variation remains, suggesting that
much can be improved in the detection of two of the
major diseases of this time.
Conclusion
It can be concluded that even after adjustment for patient
and practice characteristics, there is a wide difference
between general practices in the prevalence rates of diag-
nosed hypertension and diabetes mellitus. The reasons for
this wide variation are unknown and further research in
this area is needed.
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